AVCT ... Affirmer Covid-19 Reagents & Testing9 Apr 2020 20:23
From the RNS...
"Avacta is already generating Affimer reagents that detect the COVID-19 virus"
"Avacta will own the intellectual property relating to the COVID-19 Affimer-reagents and will retain all the commercial rights to future products."
"Hundreds of millions of tests will be needed for population screening and we will be working hard to deliver an Affimer based solution on Cytiva's platform, and potentially on the platforms of other partners with whom we are in active discussion, as soon as possible. "